Drug screening model meets cancer organoid technology
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference106 articles.
1. Phase II and phase III failures: 2013-2015;Harrison;Nat. Rev. Drug Discov.,2016
2. Cancer modeling meets human organoid technology;Tuveson;Science,2019
3. How to find the right drug for each patient? Advances and challenges in pharmacogenomics;Kalamara;Curr Opin Syst Biol,2018
4. Role of Patient Derived Cell Lines and Xenograft in Cancer Research. The Pharmstudent;Srivastava,2016
5. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix;Scherer;J Exp Med,1953
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Application and prospect of organoid technology in breast cancer;Frontiers in Immunology;2024-08-26
2. Integrating organoids and organ-on-a-chip devices;Nature Reviews Bioengineering;2024-07-02
3. Research progress on the application of organoids in gynecological tumors;Frontiers in Pharmacology;2024-06-26
4. Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo;Human Cell;2024-06-03
5. Chronotoxici‐Plate Containing Droplet‐Engineered Rhythmic Liver Organoids for Drug Toxicity Evaluation;Advanced Science;2024-05-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3